[Journal logo]

Volume 67 
Part 7 
Page o1669  
July 2011  

Received 21 May 2011
Accepted 7 June 2011
Online 18 June 2011

Key indicators
Single-crystal X-ray study
T = 296 K
Mean [sigma](C-C) = 0.004 Å
R = 0.047
wR = 0.135
Data-to-parameter ratio = 13.4
Details
Open access

Bis[(1-methyl-1H-tetrazol-5-yl)sulfanyl]ethane

aSchool of Environmental Science & Engineering, Chang'an University, Xi'an 710054, Shaanxi, People's Republic of China, and bCollege of Chemistry and Materials Science, Northwest University, Xi'an 710069, Shaanxi, People's Republic of China
Correspondence e-mail: northwindy@126.com

The title compound, C6H10N8S2, was prepared by the nucleophilic substitution reaction of 5-mercapto-1-methyltetrazole and dichloroethane. In the crystal, the molecule possesses an approximate non-crystallographic twofold symmetry axis. The crystal packing is stabilized by weak intermolecular C-H...N and [pi]-[pi] interactions [centroid-centroid distances = 3.448 (6), 3.5085 (5) and 3.4591 (2) Å]. The two five-membered rings form a dihedral angle of 1.9 (2)°.

Related literature

For the synthesis and structures of closely related compounds, see: She et al. (2006[She, J.-B., Zhang, G.-F., Dou, Y.-L., Fan, X.-Z. & Li, J.-Z. (2006). Acta Cryst. E62, o402-o404.]); Wei et al. (2011[Wei, W., Xia, Z., Chen, S. & Gao, S. (2011). Acta Cryst. E67, o999.]). For the pharmacological activity of tetrazole-containing compounds, see: Gilchrist (1992[Gilchrist, T. L. (1992). Heterocyclic Chemistry, 2nd ed., pp. 505-511. New York: John Wiley & Sons.]); Armour et al. (1996[Armour, D. R., Chung, K. M. L., Congreve, M., Evans, B., Guntrip, S., Hubbard, T., Kay, C., Middlemiss, D., Mordaunt, J. E., Pegg, N. A., Vinader, M. V., Ward, P. & Watson, S. P. (1996). Bioorg. Med. Chem. Lett. 6, 1015-1020.]); Upadhayaya et al. (2004[Upadhayaya, R. S., Jain, S., Sinha, N., Kishore, N., Chandra, R. & Arora, S. K. (2004). Eur. J. Med. Chem. 39, 579-592.]). For applications of tetrazole derivatives in coordination chemistry and as energetic materials, see: Zhao et al. (2008[Zhao, H., Qu, Z. R., Ye, H. Y. & Xiong, R. G. (2008). Chem. Soc. Rev. 37, 84-100.]); Wang et al. (2009[Wang, W. T., Chen, S. P. & Gao, S. L. (2009). Eur. J. Inorg. Chem. 23, 3475-3480.]).

[Scheme 1]

Experimental

Crystal data
  • C6H10N8S2

  • Mr = 258.34

  • Triclinic, [P \overline 1]

  • a = 7.5905 (17) Å

  • b = 7.9958 (17) Å

  • c = 10.398 (2) Å

  • [alpha] = 95.206 (3)°

  • [beta] = 92.922 (3)°

  • [gamma] = 115.109 (2)°

  • V = 566.3 (2) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.46 mm-1

  • T = 296 K

  • 0.31 × 0.27 × 0.04 mm

Data collection
  • Bruker APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2002[Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.868, Tmax = 0.982

  • 2874 measured reflections

  • 1972 independent reflections

  • 1454 reflections with I > 2[sigma](I)

  • Rint = 0.017

Refinement
  • R[F2 > 2[sigma](F2)] = 0.047

  • wR(F2) = 0.135

  • S = 1.39

  • 1972 reflections

  • 147 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.26 e Å-3

  • [Delta][rho]min = -0.26 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
C1-H1A...N4i 0.96 2.49 3.413 (5) 161
C6-H6B...N5ii 0.96 2.43 3.355 (5) 161
Symmetry codes: (i) -x+1, -y+1, -z+1; (ii) -x+1, -y+2, -z+2.

Data collection: SMART (Bruker, 2002[Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2002[Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: SHELXL97.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: YK2010 ).


Acknowledgements

We gratefully acknowledge the National Science Foundation of China (No. 20873100) and the Natural Science Foundation of Shaanxi Province (No. FF10091).

References

Armour, D. R., Chung, K. M. L., Congreve, M., Evans, B., Guntrip, S., Hubbard, T., Kay, C., Middlemiss, D., Mordaunt, J. E., Pegg, N. A., Vinader, M. V., Ward, P. & Watson, S. P. (1996). Bioorg. Med. Chem. Lett. 6, 1015-1020.  [CrossRef] [ChemPort]
Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Gilchrist, T. L. (1992). Heterocyclic Chemistry, 2nd ed., pp. 505-511. New York: John Wiley & Sons.
She, J.-B., Zhang, G.-F., Dou, Y.-L., Fan, X.-Z. & Li, J.-Z. (2006). Acta Cryst. E62, o402-o404.  [CSD] [CrossRef] [details]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Upadhayaya, R. S., Jain, S., Sinha, N., Kishore, N., Chandra, R. & Arora, S. K. (2004). Eur. J. Med. Chem. 39, 579-592.  [ISI] [CrossRef] [PubMed] [ChemPort]
Wang, W. T., Chen, S. P. & Gao, S. L. (2009). Eur. J. Inorg. Chem. 23, 3475-3480.
Wei, W., Xia, Z., Chen, S. & Gao, S. (2011). Acta Cryst. E67, o999.  [CrossRef] [details]
Zhao, H., Qu, Z. R., Ye, H. Y. & Xiong, R. G. (2008). Chem. Soc. Rev. 37, 84-100.  [ISI] [CrossRef] [PubMed]


Acta Cryst (2011). E67, o1669  [ doi:10.1107/S1600536811021957 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.